Michael Via
Basic profileMichael Via is an Endocrinology/Metabolic physician affiliated with Mount Sinai Beth Israel. OpenAlex indexes 58 publications with 992 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20253 payments$1,682
- Novo Nordisk IncProgram year20252 payments$1,628
- Chiesi USA, Inc.Program year20252 payments$625
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
57.3%Insulin Analog15.9%Novolog Flexpen23%Basaglar Kwikpen U-10019%Tresiba Flextouch U-20016%Humalog Kwikpen U-10013%Lantus Solostar9%Levemir Flextouch6%Levemir Flexpen5%Insulin Lispro Kwikpen U-1004%Novolog3%Tresiba Flextouch U-1003%Part D<11 patientsBiguanide (metformin)10.3%Metformin Hcl72%Metformin Hcl Er28%Part D≥61 patients+ 8 more classes in this area
Hormonal (systemic)
22.3%l-Thyroxine17.7%Levothyroxine Sodium76%Synthroid24%Part D≥98 patientsCalcium-sensing Receptor Agonist1.7%Cinacalcet Hcl100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
17.9%Statin7.5%Atorvastatin Calcium65%Rosuvastatin Calcium35%Part D≥35 patientsAngiotensin receptor blocker (ARB)3.6%Losartan Potassium88%Valsartan12%Part D<11 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Bressman, MD
Mount Sinai Beth Israel
Rachel Saunders Pullman
Mount Sinai Beth Israel
Ramesh Gowda, MD
Mount Sinai Beth Israel
Michael Serby, MD
Mount Sinai Beth Israel
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”